Immediate and Residual Effects of Functional Chewing Gum on Concentration

NCT05544500 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2022-12-27

No results posted yet for this study

Summary

Previous research suggests that chewing gum may influence several functions including attention and alertness. Gum can also be used as a vehicle for delivering ingredients that have the ability to modulate attention and mood. This study will explore the effects of a functional gum containing a proprietary composition of a herbal extract and vitamins. These effects will be compared to the effects of a basic sugar-free gum and to a tablet which will include the same ingredients as the basic sugar-free gum. Effects will be explored on computerised measures of attention/concentration and via ratings of current mood. The study will assess the immediate effects of chewing gum as well as the effects 1 hour later.

There will be an initial remote screening session followed by visits to the laboratory on 4 separate occasions: an introductory/training visit and three active study days.

Conditions

  • Cognitive Change

Interventions

DIETARY_SUPPLEMENT

Functional Gum

Functional gum containing a proprietary composition of a herbal extract and vitamins

DIETARY_SUPPLEMENT

Basic Chewing Gum

Sugar-free chewing gum

DIETARY_SUPPLEMENT

Placebo

Sugar-free tablet

Sponsors & Collaborators

  • Perfetti van Melle SPA

    collaborator UNKNOWN
  • Northumbria University

    lead OTHER

Principal Investigators

  • Crystal Haskell-Ramsay · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-05
Primary Completion
2022-09-15
Completion
2022-09-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05544500 on ClinicalTrials.gov